Alkylsulphonamide quinolines

Details for Australian Patent Application No. 2006325572 (hide)

Owner AstraZeneca AB

Inventors Simpson, Thomas; Li, Yan; Alhambra, Cristobal; Kang, James; Woods, James; Albert, Jeffrey; Koether, Gerard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006325572

PCT Pub. Number WO2007/069977

Priority 60/821,016 01.08.06 US; 60/749,431 12.12.05 US

Filing date 11 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 24 February 2011

International Classifications

C07D 215/52 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/069977 Priority application(s): WO2007/069977

24 February 2011 Application Accepted

  Published as AU-B-2006325572

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006325573-Novel N- (fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4.

2006325565-Screening arrangement